2014Guoji yiyao weisheng daobaoRequires access

Dosage and efficacy of simvastatin for hyperlipidemia in elderly patients

Lei Zhou

Open publisher page 0 citations

Abstract

Objectives To explore the dosage and efficacy of simvastatin for hyperlipidemia in elderly patients.Methods 94 elderly hyperlipidemia patients were randomly divided into a large dosage group and a small dosage group,47 cases for each group.These two groups were treated with simvastatin 20 mg/d and 10 mg/d,respectively.The efficacies of both groups were observed.Results All lipid indicators were enormously better in the large dosage group than in the small dosage group after the treatment (P < 0.05).The efficacy was 95.74% in the large dosage group and was 82.98% in the small dosage group (P < 0.05).There was no statistical difference in the incidence of adverse reactions between the two groups (P > 0.05).Conclusions Large dosage (20 mg/d) of simvastatin for elderly hyperlipidemia patients is quite effective and safe. Key words: Hyperlipidemia;  Simvastatin;  Dosage

About this research paper

What this paper is about

Objectives To explore the dosage and efficacy of simvastatin for hyperlipidemia in elderly patients.Methods 94 elderly hyperlipidemia patients were randomly divided into a large dosage group and a small dosage group,47 cases for each group.These two groups were treated with simvastatin 20 mg/d and 10 mg/d,respectively.The efficacies of both groups were observed.Results All lipid indicators were enormously better in the large dosage group than in the small dosage group after the treatment (P < 0.05).The efficacy was 95.74% in the large dosage group and was 82.98% in the small dosage group (P < 0.05).There was no statistical difference in the incidence of adverse reactions between the two groups (P > 0.05).Conclusions Large dosage (20 mg/d) of simvastatin for elderly hyperlipidemia patients is quite effective and safe. Key words: Hyperlipidemia;  Simvastatin;  Dosage

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objectives To explore the dosage and efficacy of simvastatin for hyperlipidemia in elderly patients.Methods 94 elderly hyperlipidemia patients were randomly divided into a large dosage group and a small dosage group,47 cases for each group.These two groups were treated with simvastatin 20 mg/d and 10 mg/d,respectively.The efficacies of both groups were observed.Results All lipid indicators were enormously better in the large dosage group than in the small dosage group after the treatment (P < 0.05).The efficacy was 95.74% in the large dosage group and was 82.98% in the small dosage group (P < 0.05).There was no statistical difference in the incidence of adverse reactions between the two groups (P > 0.05).Conclusions Large dosage (20 mg/d) of simvastatin for elderly hyperlipidemia patients is quite effective and safe. Key words: Hyperlipidemia;  Simvastatin;  Dosage

Key concepts: Simvastatin, Hyperlipidemia, Medicine, Dosage form, Significant difference, Clinical efficacy, Incidence (geometry), Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Dosage and efficacy of simvastatin for hyperlipidemia in elderly patients — Research Paper | ScholarLens